Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Safety and Occurrence of Influenza-like Illness Following Administration of Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine Celtura

NCT01037855 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01037855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01037855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Safety and Occurrence of Influenza-like Illness Following Administration of Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine Celtura
Lead sponsor
Novartis Vaccines
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
January 31, 2011
Enrollment
4,028 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

a new flu virus of swine origin, novel influenza a (h1n1)